Adjuvant-like biomimetic nanovesicles combat New Delhi metallo-β-lactamases (NDMs) producing superbugs infections
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Antibiotic Resistance in Bacteria · Inhalation and Respiratory Drug Delivery · Pneumocystis jirovecii pneumonia detection and treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. NDM metallo-β-lactamases and their bacterial producers in health care settings10.1128/CMR.00115-18 ↗
2. The emerging NDM carbapenemases10.1016/j.tim.2011.09.005 ↗
3. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide10.1111/1469-0691.12719 ↗
4. Hydrolysis of cephalexin and meropenem by New Delhi metallo-β-lactamase: the substrate protonation mechanism is drug dependent10.1039/C6CP08769H ↗
5. Intentional use of carbapenem antibiotics for valproic acid toxicity: a case report10.1111/jcpt.12705 ↗
6. Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant enterobacteriaceae infections10.1093/cid/ciw636 ↗
7. Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates10.1038/ncomms12406 ↗
8. The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis10.1038/s41467-017-02339-w ↗
9. Overcoming differences: the catalytic mechanism of metallo-β-lactamases10.1016/j.febslet.2015.08.015 ↗
10. The rapid spread of carbapenem-resistant Enterobacteriaceae10.1016/j.drup.2016.09.002 ↗
11. The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase10.1038/s41467-019-11503-3 ↗
12. Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance10.1038/nature13445 ↗
13. Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 β-lactamase10.1007/s10156-012-0528-y ↗
14. β-Lactamases and β-Lactamase Inhibitors in the 21st Century10.1016/j.jmb.2019.04.002 ↗
15. The outer membrane is an essential load-bearing element in Gram-negative bacteria10.1038/s41586-018-0344-3 ↗
16. pH‐responsive polymer–drug conjugate: an effective strategy to combat the antimicrobial resistance10.1002/adfm.202002655 ↗
17. A macromolecule reversing antibiotic resistance phenotype and repurposing drugs as potent antibiotics
18. Therapeutic strategies to combat antibiotic resistance10.1016/j.addr.2014.10.027 ↗
19. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy10.1073/pnas.1522080113 ↗
20. PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern10.1021/jp211515g ↗
21. Pathogen-specific polymeric antimicrobials with significant membrane disruption and enhanced photodynamic damage to inhibit highly opportunistic bacteria10.1021/acsnano.8b07251 ↗
22. Bioresponsive nanoparticles targeted to infectious microenvironments for sepsis management
23. pH-Responsive, light-triggered on-demand antibiotic release from functional metal-organic framework for bacterial infection combination therapy10.1002/adfm.201800011 ↗
24. Nanoparticle biointerfacing by platelet membrane cloaking10.1038/nature15373 ↗
25. Platelets interact with bacterial pathogens10.1160/TH09-08-0561 ↗
26. Platelets in defense against bacterial pathogens10.1007/s00018-009-0210-4 ↗
27. Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis10.1021/acsnano.7b07720 ↗
28. Remote-loaded platelet vesicles for disease-targeted delivery of therapeutics10.1002/adfm.201801032 ↗
29. From structure to function: pH-switchable antimicrobial nano-self-assemblies10.1021/acsami.8b18618 ↗
30. Increased wound pH as an indicator of local wound infection in second degree burns10.1016/j.burns.2014.10.023 ↗
31. Selective killing ofHelicobacter pyloriwith pH-responsive helix–coil conformation transitionable antimicrobial polypeptides10.1073/pnas.1710408114 ↗
32. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors10.1038/s41467-018-02828-6 ↗
33. Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase10.1038/s41420-018-0029-6 ↗
34. Klebsiella pneumoniae expressing VIM-1 metallo-β-lactamase is resensitized to cefotaxime via thiol-mediated zinc chelation10.1128/IAI.00756-19 ↗
35. Membrane anchoring stabilizes and favors secretion of New Delhi metallo-β-lactamase10.1038/nchembio.2083 ↗
36. Macrocycles-assisted polymeric self-assemblies fabricated by host–guest complexation and their applications10.1039/D0MA00625D ↗
37. PAMAM dendrimer - cell membrane interactions10.1016/j.cis.2018.06.005 ↗
38. Crosstalk between platelet and bacteria: a therapeutic prospect10.2174/1381612825666190925163347 ↗
39. Porous silicon nanoparticle delivery of tandem peptide anti-infectives for the treatment ofpseudomonas aeruginosalung infections10.1002/adma.201701527 ↗
40. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes10.1074/jbc.M308643200 ↗
41. Endosomal size and membrane leakiness influence proton sponge-based rupture of endosomal vesicles10.1021/acsnano.7b07583 ↗
42. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents10.1007/s40272-013-0017-5 ↗
43. A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 min10.1007/BF03189806 ↗
44. Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia10.1038/s41564-018-0147-1 ↗
45. Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin10.1007/s00134-019-05890-w ↗
46. Body temperature alterations in the critically ill10.1007/s00134-004-2166-z ↗